Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

February 28, 2011

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

SUVRETTA CAPITAL MANAGEMENT, LLC

2. Date of Event Requiring Statement (Month/Day/Year)
04/22/2024

3. Issuer Name and Ticker or Trading Symbol
Benitec Biopharma Inc. [BNTC]

(Last)

(First)

(Middle)

540 MADISON AVENUE, 7TH FLOOR

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	__X__ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

5. If Amendment, Date Original Filed (Month/Day/Year)

(Street)

NEW YORK, NY 10022

6. Individual or Joint/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common stock, par value $0.0001 per share	1,470,179 ⁽¹⁾ ⁽²⁾	I ⁽⁴⁾	I ⁽⁴⁾
Common stock, par value $0.0001 per share	221,111 ⁽¹⁾ ⁽³⁾	I ⁽⁴⁾	I ⁽⁴⁾

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Pre-Funded Warrants ⁽¹²⁾	09/15/2022	⁽⁵⁾	Common Stock	588,235 ⁽⁶⁾	$ 0.0017	I ⁽¹¹⁾	I ⁽¹¹⁾
Pre-Funded Warrants ⁽¹²⁾	08/11/2023	⁽⁵⁾	Common Stock	4,605,000 ⁽⁷⁾	$ 0.0001	I ⁽¹¹⁾	I ⁽¹¹⁾
Pre-Funded Warrants ⁽¹²⁾	04/22/2024	⁽⁵⁾	Common Stock	1,726,203 ⁽⁸⁾	$ 0.0001	I ⁽¹¹⁾	I ⁽¹¹⁾
Pre-Funded Warrants ⁽¹²⁾	08/11/2023	⁽⁵⁾	Common Stock	576,347 ⁽⁹⁾	$ 0.0001	I ⁽¹¹⁾	I ⁽¹¹⁾
Pre-Funded Warrants ⁽¹²⁾	04/22/2024	⁽⁵⁾	Common Stock	276,353 ⁽¹⁰⁾	$ 0.0001	I ⁽¹¹⁾	I ⁽¹¹⁾
Series 2 Common Warrants ⁽¹²⁾	12/09/2022	12/09/2027	Common Stock	588,236 ⁽⁶⁾	$ 1.9299	I ⁽¹¹⁾	I ⁽¹¹⁾
Common Warrants ⁽¹²⁾	08/11/2023	08/11/2028	Common Stock	4,605,000 ⁽⁷⁾	$ 3.86	I ⁽¹¹⁾	I ⁽¹¹⁾
Common Warrants ⁽¹²⁾	08/11/2023	08/11/2028	Common Stock	576,347 ⁽⁹⁾	$ 3.86	I ⁽¹¹⁾	I ⁽¹¹⁾

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE 7TH FLOOR NEW YORK, NY 10022		X
Cowen Aaron C/O SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE, 7TH FLOOR NEW YORK, NY 10022		X
Averill Madison Master Fund, Ltd. C/O SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE, 7TH FLOOR NEW YORK, NY 10022		X
Averill Master Fund, Ltd. C/O SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE, 7TH FLOOR NEW YORK, NY 10022		X

Signatures

By: /s/Andrew Nathanson, Suvretta Capital Management, LLC, General Counsel & Chief Compliance Officer		05/02/2024
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	See Exhibit 99.1
(2)	See Exhibit 99.1
(3)	See Exhibit 99.1
(4)	See Exhibit 99.1
(5)	See Exhibit 99.1
(6)	See Exhibit 99.1
(7)	See Exhibit 99.1
(8)	See Exhibit 99.1
(9)	See Exhibit 99.1
(10)	See Exhibit 99.1
(11)	See Exhibit 99.1
(12)	See Exhibit 99.1
Remarks: Exhibit List:-------------Exhibit 99.1 - Explanation of ResponsesExhibit 99.2 - Joint Filer InformationExhibit 99.3 - Joint Filers' Signatures

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.